Literature DB >> 8058648

Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides.

C Oliyai1, R T Borchardt.   

Abstract

The influence of the primary sequence on the degradation of Asp4 residues (e.g., formation of the cyclic imide and Asp-X and/or X-Asp amide bond hydrolysis) was investigated using Val-Tyr-Y-Asp-X-Ala hexapeptides. These reactions were proposed to involve cyclization, which would duly be sensitive to steric hindrance. The effects on the rates of individual degradation routes and product distribution under both acidic and alkaline conditions were assessed upon substitutions made on the C-terminal side (X) and on the N-terminal side (Y) of the Asp residue. As expected, the rate of intramolecular formation of cyclic imide and, thus, the product yield were most affected by the size of the amino acid on the C-terminal side of the Asp residue. However, such structural changes had little or no impact on the rate of Asp-X and Y-Asp amide bond hydrolysis. In the former case, the substituted site was one atom removed from the reaction site, accounting for the diminished steric effect observed. As for the latter, the site of substitution was not a participant in the reaction itself, and hence, the rate was unperturbed by this modification. Placing Ser and Val C terminally to the Asp residue prompted racemization and peptide bond hydrolysis to occur under alkaline conditions. N-Terminal substitution of Pro with Gly had no effect on the rate of isomerization via cyclic imide formation but greatly enhanced the rate of Y-Asp amide bond hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058648     DOI: 10.1023/a:1018944800691

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.

Authors:  K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Cleavage at aspartyl-prolyl bonds.

Authors: 
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

3.  Cleavage at aspartic acid.

Authors:  A S Inglis
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Cooperative effects of functional groups in peptides. II. Elimination reactions in aspartyl-(O-acyl)-serine derivatives.

Authors:  Y Shalitin; S A Bernhard
Journal:  J Am Chem Soc       Date:  1966-10-20       Impact factor: 15.419

5.  Calcium affects the spontaneous degradation of aspartyl/asparaginyl residues in calmodulin.

Authors:  I M Ota; S Clarke
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

6.  Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins.

Authors:  R C Stephenson; S Clarke
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

7.  Relationship between the catalytic center and the primary degradation site of triosephosphate isomerase: effects of active site modification and deamidation.

Authors:  A Q Sun; K U Yüksel; R W Gracy
Journal:  Arch Biochem Biophys       Date:  1992-03       Impact factor: 4.013

8.  Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.

Authors:  C Oliyai; R T Borchardt
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

9.  Side reactions in peptide synthesis. VII. Sequence dependence in the formation of aminosuccinyl derivatives from beta-benzyl-aspartyl peptides.

Authors:  M Bodanszky; J Z Kwei
Journal:  Int J Pept Protein Res       Date:  1978-08

10.  Deamidation via cyclic imide in asparaginyl peptides.

Authors:  S Capasso; L Mazzarella; F Sica; A Zagari
Journal:  Pept Res       Date:  1989 Mar-Apr
View more
  16 in total

1.  Toward proteome-scale identification and quantification of isoaspartyl residues in biological samples.

Authors:  Hongqian Yang; Eva Y M Fung; Alexander R Zubarev; Roman A Zubarev
Journal:  J Proteome Res       Date:  2009-10       Impact factor: 4.466

Review 2.  Fragmentation of monoclonal antibodies.

Authors:  Josef Vlasak; Roxana Ionescu
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.

Authors:  Sejal Gandhi; Da Ren; Gang Xiao; Pavel Bondarenko; Christopher Sloey; Margaret Speed Ricci; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2011-08-16       Impact factor: 4.200

5.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

6.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.

Authors:  David Ouellette; Chris Chumsae; Anca Clabbers; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2013-04-22       Impact factor: 5.857

7.  Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice.

Authors:  E Kim; J D Lowenson; D C MacLaren; S Clarke; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 8.  Predicting protein decomposition: the case of aspartic-acid racemization kinetics.

Authors:  M J Collins; E R Waite; A C van Duin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-01-29       Impact factor: 6.237

9.  Anion binding mediated precipitation of a peptibody.

Authors:  Atul Saluja; Shon Crampton; Eva Kras; R Matthew Fesinmeyer; Richard L Remmele; Linda O Narhi; David N Brems; Yatin R Gokarn
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

10.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.